AKT1 and cancer: Deregulation of PI3K pathway PI3K/AkT/mTOR leads to elevated PIP3 levels and downstream activation of Akt (directly or indirectly), which might be involved in the pathology of cancer, inflammation, immune disorders, and cardiovascular diseases.